Evaluation of hemostatic effect of BAY 86-6150, a recombinant FVIIa variant, in antibody-induced hemophilic whole blood under flow conditions

PO-MO-129

  • DOI, M.
  • SUGIMOTO, M.
  • MATSUI, H.
  • MATSUNARI, Y.
  • SHIMA, M.
  • GU, J.
  • KIM, J.
  • SIM, D.
  • LAUX, V.
  • MURPHY, J.
  • MYLES, T.

  • *Department of Regulatory Medicine for Thrombosis; †Department of Pediatrics, Nara Medical University, Kashihara, Japan and *U.S. Innovation Center, Bayer HealthCare LLC, San Francisco, USA

Haemophilia 18:p 104, July 2012.
Copyright © 2012 Blackwell Publishing Ltd.
View full text|Download PDF